Obesity is recognized as a condition impacting female fertility throughout the process of conception, including natural and assisted reproductive technologies. Excess body fat can interfere with the regulation of the **hypothalamus**, **pituitary gland**, and **ovaries**. It also affects insulin signaling, inflammatory processes, oocyte quality, embryo development, and the receptivity of the uterine lining.
Impact on Assisted Reproductive Technologies
The review examines the connections between obesity and infertility, decreased effectiveness of **ART**, implantation difficulties, miscarriage, and lower live birth rates. These relationships are influenced by individual reproductive and metabolic characteristics. Specific conditions such as polycystic ovary syndrome, advanced age, reduced ovarian reserves, recurrent implantation failure, and recurrent pregnancy loss are highlighted in the context of obesity’s impact. The review considers strategies for weight reduction before fertility treatment, including lifestyle changes, glucagon-like peptide-1 receptor agonists, **tirzepatide**, and bariatric surgery. These approaches are evaluated for their potential to improve reproductive outcomes, the possible delay in treatment, and considerations for safety during pregnancy.
Complex Phenotype and Personalized Treatment
It is emphasized that obesity should be viewed as a complex, phenotype-dependent reproductive-metabolic condition. Individualized fertility treatment planning is recommended. The research suggests a need to move beyond simply categorizing fertility issues based on body mass index.